Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / TGTX - TG Therapeutics Positive Data And Other News: The Good Bad And Ugly Of Biopharma

TGTX - TG Therapeutics Positive Data And Other News: The Good Bad And Ugly Of Biopharma

TG Therapeutics Inc.

TG Therapeutics Reports Positive Data From Umbralisib Trial

TG Therapeutics Inc. (TGTX) reported positive top line data from its Phase 3 trial pertaining to Umbralisib. The trial seeks to evaluate the combination of the drug candidate with ublituximab compared to obinutuzumab plus chlorambucil in subjects suffering from previously untreated and relapsed or refractory chronic lymphocytic leukemia (CLL). The trial will be stopped early for superior efficacy.

TG Therapeutics stated that the trial met its primary endpoint which was related to progression-free survival. The interim analysis showed a statistically significant improvement in progression-free survival

Read more ...
Stock Information
Company Name: TG Therapeutics Inc.
Stock Symbol: TGTX
Market: NASDAQ
Website: tgtherapeutics.com
Menu
TGTX TGTX Quote TGTX Short TGTX News TGTX Articles TGTX Message Board
Get TGTX Alerts

News, Short Squeeze, Breakout and More Instantly...